Prevalence of Lymphatic Filariasis in Ndiagu Ikenga Ogidi, Idemili North LGA, Anambra State Nigeria

Orji, N. M.

doi:10.25240/tjans.2018.2.2.08

Cited by 1 publication

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, 22.30% was reported using standard parasitological techniques (thick film smear) with farming and fishing as risks of contracting the disease among eight communities of Ukwa East Local Government Area of Abia State [ 54 ]. An overall microfilaria prevalence of 20.20% from standard parasitological methods with exposure to vectors, presence of stagnant water, and farming as risks of contraction of the disease were reported among inhabitants of Ogidi in Idemili North LGA of Anambra State [ 55 ]. Similarly, in Yakurr LGA, a microfilaria prevalence of 6.10% through thick blood smear microscopy with lymphedema (0.30%) and exposure of residents to vectors were reported in 4 communities [ 56 ].…”

Section: Resultsmentioning

confidence: 99%

A review of epidemiology of lymphatic filariasis in Nigeria

Waje,

Iliyasu,

Yaki

et al. 2024

Pan Afr Med J

View full text Add to dashboard Cite

Lymphatic filariasis is a neglected tropical disease that affects the lymphatic system of humans. The major etiologic agent is a nematode called Wuchereria bancrofti, but Brugia malayi and Brugia timoriare sometimes encountered as causative agents. Mosquitoes are the vectors while humans the definitive hosts respectively. The burden of the disease is heavier in Nigeria than in other endemic countries in Africa. This occurs with increasing morbidity and mortality at different locations within the country, the World Health Organization recommended treatments for lymphatic filariasis include the use of Albendazole (400mg) twice per year in co-endemic areas with loa loa, Ivermectin (200mcg/kg) in combination with Albendazole (400mg) in areas that are co-endemic with onchocerciasis, ivermectin (200mcg/kg) with diethylcarbamazine citrate (DEC) (6mg/kg) and albendazole (400mg) in areas without onchocerciasis. This paper covered a systematic review, meta-analysis, and scoping review on lymphatic filariasis in the respective geopolitical zones within the country. The literature used was obtained through online search engines including PubMed and Google Scholar with the heading “lymphatic filariasis in the name of the state”, Nigeria. This review revealed an overall prevalence of 11.18% with regional spread of Northwest (1.59%), North Central and North East, (4.52%), South West (1.26%), and South-South with South East (3.81%) prevalence. The disease has been successfully eliminated in Argungu local government areas (LGAs) of Kebbi State, Plateau, and Nasarawa States respectively. Most clinical manifestations (31.12%) include hydrocele, lymphedema, elephantiasis, hernia, and dermatitis. Night blood samples are appropriate for microfilaria investigation. Sustained MDAs, the right testing methods, early treatment of infected cases, and vector control are useful for the elimination of lymphatic filariasis for morbidity management and disability prevention in the country. Regional control strategies, improved quality monitoring of surveys and intervention programs with proper records of morbidity and disability requiring intervention are important approaches for the timely elimination of the disease in Nigeria.

show abstract

Section: Resultsmentioning

confidence: 99%